National

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccꦑine doses in November this year.

Serum Institute Of India Eyes Exports With Enhanced Covid-19 🅷Vaccine Output: Adar Poonawalla
info_icon

The Serum Institute of I꧒ndia (SII) has increased its capacity to produce 240 million AstraZeneca Covid-19 doses making it capable to export large volumes🔜 of the vaccine.

According to Reuters, the company’s CEO Adar Poonawalla said it will produce 220-240 mi♔llion AstraZeneca vaccine dosꦑes.

He added the company may be able to export up to 30 million dosꦗes a month in November and December.

He said th🐠e company has revamped its infrastructu𝄹re to produce the required Covid-19 doses.

Poonaawall༒a said SII would also make the single-dose Sputnik🎶 Light vaccine.

He also♚ said the company would also produce 50 million to 100 million doses of the Novavax𝓡 vaccine by the end of this year.